William Michael Kavanaugh

SVP & Chief Scientific Officer, FIVE PRIME THERAPEUTICS, INC.

Companies

CytomX Therapeutics, Inc.CSO, Head Res.&Non-Clin. Dev. Oct 7, 2015 to Feb 19, 2020¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCytomX Therapeutics, Inc., CSO, Head Res.&Non-Clin. Dev.